These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36475810)
1. Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database. Sarwar A; Bonder A; Hassan L; Malik MS; Novack V; Curry M; Ahmed M AJR Am J Roentgenol; 2023 May; 220(5):727-735. PubMed ID: 36475810 [No Abstract] [Full Text] [Related]
2. Locoregional Therapies for Hepatocellular Carcinoma prior to Liver Transplant: Comparative Pathologic Necrosis, Radiologic Response, and Recurrence. Mosenthal M; Adams W; Cotler S; Ding X; Borge M; Malamis A; Lee D; Thomas T; Jawahar A; Amin P; Molvar C J Vasc Interv Radiol; 2024 Apr; 35(4):506-514. PubMed ID: 38123127 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology. Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713 [TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Lewandowski RJ; Kulik LM; Riaz A; Senthilnathan S; Mulcahy MF; Ryu RK; Ibrahim SM; Sato KT; Baker T; Miller FH; Omary R; Abecassis M; Salem R Am J Transplant; 2009 Aug; 9(8):1920-8. PubMed ID: 19552767 [TBL] [Abstract][Full Text] [Related]
5. Combined transarterial chemoembolization and thermal ablation in candidates to liver transplantation with hepatocellular carcinoma: pathological findings and post-transplant outcome. Fronda M; Susanna E; Doriguzzi Breatta A; Gazzera C; Patrono D; Piccione F; Bertero L; Ciferri F; Carucci P; Gaia S; Rolle E; Vocino Trucco G; Bergamasco L; Tandoi F; Cassoni P; Romagnoli R; Fonio P; Calandri M Radiol Med; 2024 Jul; 129(7):1086-1097. PubMed ID: 38829544 [TBL] [Abstract][Full Text] [Related]
6. Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation. Zori AG; Ismael MN; Limaye AR; Firpi R; Morelli G; Soldevila-Pico C; Suman A; Vogel JD; Lazarowicz M; Geller BS; Toskich B; Gonzalo DH; Johnson MW; Cabrera R Am J Clin Oncol; 2020 May; 43(5):325-333. PubMed ID: 32079854 [TBL] [Abstract][Full Text] [Related]
7. Definitive locoregional therapy (LRT) versus bridging LRT and liver transplantation with wait-and-not-treat approach for very early stage hepatocellular carcinoma. Habibollahi P; Hunt S; Bitterman T; Gade TP; Soulen MC; Nadolski G Diagn Interv Radiol; 2018 Jul; 24(4):213-218. PubMed ID: 30091712 [TBL] [Abstract][Full Text] [Related]
8. Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation. Zhang W; Xu AH; Wang W; Wu YH; Sun QL; Shu C BMC Cancer; 2019 Nov; 19(1):1041. PubMed ID: 31690274 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Moreno-Luna LE; Yang JD; Sanchez W; Paz-Fumagalli R; Harnois DM; Mettler TA; Gansen DN; de Groen PC; Lazaridis KN; Narayanan Menon KV; Larusso NF; Alberts SR; Gores GJ; Fleming CJ; Slettedahl SW; Harmsen WS; Therneau TM; Wiseman GA; Andrews JC; Roberts LR Cardiovasc Intervent Radiol; 2013 Jun; 36(3):714-23. PubMed ID: 23093355 [TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study. Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511 [TBL] [Abstract][Full Text] [Related]
11. Transarterial Radioembolization versus Transarterial Chemoembolization Plus Percutaneous Ablation for Unresectable, Solitary Hepatocellular Carcinoma of ≥3 cm: A Propensity Score-Matched Study. Yu Q; Thapa N; Karani K; Navuluri R; Ahmed O; Van Ha T J Vasc Interv Radiol; 2022 Dec; 33(12):1570-1577.e1. PubMed ID: 36100064 [TBL] [Abstract][Full Text] [Related]
12. Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis. Patel MV; Davies H; Williams AO; Bromilow T; Baker H; Mealing S; Holmes H; Anderson N; Ahmed O J Med Econ; 2023; 26(1):1061-1071. PubMed ID: 37632520 [TBL] [Abstract][Full Text] [Related]
13. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453 [TBL] [Abstract][Full Text] [Related]
14. Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. El-Gazzaz G; Sourianarayanane A; Menon KV; Sanabria J; Hashimoto K; Quintini C; Kelly D; Eghtesad B; Miller C; Fung J; Aucejo F Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):34-41. PubMed ID: 23392796 [TBL] [Abstract][Full Text] [Related]
15. LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features. Wang D; Zhang Y; Lyu R; Jia K; Xu PJ Abdom Radiol (NY); 2024 Sep; 49(9):3045-3055. PubMed ID: 38605217 [TBL] [Abstract][Full Text] [Related]
16. Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature. Young S; Golzarian J AJR Am J Roentgenol; 2020 Jul; 215(1):223-234. PubMed ID: 32255691 [No Abstract] [Full Text] [Related]
17. National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States. Kwong AJ; Ghaziani TT; Yao F; Sze D; Mannalithara A; Mehta N Clin Gastroenterol Hepatol; 2022 May; 20(5):1142-1150.e4. PubMed ID: 34358718 [TBL] [Abstract][Full Text] [Related]
18. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Terzi E; Ray Kim W; Sanchez W; Charlton MR; Schmeltzer P; Gores GJ; Andrews JC; Smyrk TC; Heimbach JK Liver Transpl; 2015 Feb; 21(2):248-57. PubMed ID: 25371111 [TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant Candidates. Wu X; Heller M; Kwong A; Fidelman N; Mehta N J Vasc Interv Radiol; 2023 Jul; 34(7):1237-1246.e3. PubMed ID: 36804296 [TBL] [Abstract][Full Text] [Related]
20. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma. Kirchner T; Marquardt S; Werncke T; Kirstein MM; Brunkhorst T; Wacker F; Vogel A; Rodt T Abdom Radiol (NY); 2019 Apr; 44(4):1554-1561. PubMed ID: 30311050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]